東方甄選(01797.HK)升逾兩成 促銷第二日銷售額達3,000萬人民幣
東方甄選(01797.HK)今日高開1.32%,最高見36.75元。現報36.75元,升21.69%,成交2,974.84萬股,涉資9.99億元。
東方甄選表示,旗下App繼續「全場自營產品85折」優惠,於昨日(27日)銷售額升至3,000萬元人民幣,再次刷新上一日創造的1,750萬元人民幣紀錄。
行政總裁孫東旭表示,當日數十萬用戶湧入App搶購,目前多個自營產品正在緊急增加庫存,原計劃為期三日的折扣活動有可能遇到較嚴重的缺貨情況。近數日東方甄選App下載量急升,截至昨日下載量進入中國iOS購物榜頭5位,亦位列iOS免費榜第36位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.